Genericart Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg Tablet SR
Marketer
Swast Aushadhi Seva Generic Medicine Store
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Genericart Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg Tablet SR
Combifort (Glimepiride/Metformin/Pioglitazone 2mg/500mg/15mg SR Tablets) is a triple-combination medication managing blood glucose. In conjunction with diet and exercise, it enhances glycemic control in adult patients with type 2 diabetes. This medication improves insulin effectiveness, resulting in reduced blood sugar. Always adhere to your physician's prescribed dosage and regimen for Combifort. Administer with food to mitigate gastrointestinal discomfort. If a dose is missed, take it promptly unless the next dose is imminent; avoid doubling the dose. An overdose can cause hypoglycemia (low blood sugar). Concurrent use with other antidiabetic medications, alcohol, or skipped meals may increase hypoglycemia risk; regular blood glucose monitoring is essential. Common adverse effects may include nausea, diarrhea, abdominal pain, headache, increased risk of fractures, and respiratory infections. Prior to initiating treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should seek medical counsel before use. Baseline kidney function tests will be performed before commencing treatment. Limit alcohol consumption to minimize potential side effects.
Uses of Genericart Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Genericart Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Genericart Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg SR tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.
Common Side effects of Genericart Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Genericart Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Genericart Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg Extended-Release tablets should be taken with food.
How Genericart Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg Tablet SR works:
The extended-release tablet, Genericart Glimepiride/Metformin/Pioglitazone (2mg/500mg/15mg), combines three distinct anti-diabetic agents to optimize blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Finally, Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Genericart Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg SR tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The combination medication Glimepiride+Metformin+Pioglitazone (Genericart) 2mg/500mg/15mg SR tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against any risks before prescribing. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
The combined medication Glimepiride+Metformin+Pioglitazone (Genericart brand, 2mg/500mg/15mg SR tablets) is likely unsuitable for breastfeeding mothers. Available data from human studies indicate potential transfer of the drug components into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
The combination medication Glimepiride/Metformin/Pioglitazone (2mg/500mg/15mg SR) requires careful consideration in individuals with impaired kidney function. Dosage modification may be necessary. Physician consultation is advised. This medication is contraindicated in patients with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.
LiverCAUTION
The combination medication glimepiride/metformin/pioglitazone (2mg/500mg/15mg SR) requires careful administration in individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. This medication is contraindicated in patients with severe liver disease.
What if you forget to take Genericart Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg Tablet SR :
Should you forget a dose of Genericart Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg SR Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Genericart Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently